FIELD: medicine.
SUBSTANCE: invention relates to oncology and can be used for tumour treatment. Method according to the invention involves administering to a patient a substance comprising a pathogen simulator - polyinosine: polycytidylic acid (polyIC) with a delivery agent - polyethyleneimine (PEI) and treating the tumour with an intratumoural alpha emitter for 72 hours after the introduction of said substance.
EFFECT: use of the invention allows reducing the tumour size due to synergistic interaction between activation of cytoplasmic receptors to intracellular pathogens (ACSIP) and radiotherapy with an intratumoural alpha emitter.
34 cl, 1 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| IMPLANT FOR BRACHYTHERAPY AND METHOD OF INTRODUCING RADIOACTIVE SEEDS INTO BODY TISSUE | 2019 |
|
RU2808510C2 |
| RADIOACTIVE GRAINS AND APPLICATORS | 2019 |
|
RU2791920C2 |
| STOPPER FOR CONTROLLING MOVEMENT OF STYLET RELATIVE TO NEEDLE FOR BRACHYTHERAPY AND METHOD OF INTRODUCING RADIOACTIVE SEEDS INTO BODY TISSUE | 2019 |
|
RU2813795C2 |
| RADIOACTIVE GRAIN APPLICATOR | 2019 |
|
RU2808508C2 |
| DEVICES AND METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY | 2018 |
|
RU2795984C2 |
| CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS | 2018 |
|
RU2800922C2 |
| IMMUNOGENIC COMPOSITION FOR IMMUNE SYSTEM MODULATION AND USE THEREOF, METHOD FOR TREATING AND PREVENTING DISEASES, METHOD FOR INDUCING CELL REGENERATION AND METHOD FOR RESTORING IMMUNE RESPONSE | 2012 |
|
RU2678317C2 |
| IMMUNE CELLS DEFECTIVE BY Suv39h1 | 2018 |
|
RU2784531C2 |
| METHOD OF OBTAINING COMPOSITIONS INCLUDING HEAT SHOCK PROTEINS OR ALPHA-2-MACROGLOBULIN, SUITABLE FOR TREATMENT OF MALIGNANT TUMOUR AND INFECTIOUS DISEASE | 2002 |
|
RU2335295C2 |
| CANCER TREATMENT WITH TG02 | 2017 |
|
RU2749025C2 |
